Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;9(1):3-8.
doi: 10.1177/1756285615610471.

A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barré syndrome in Upper Egypt

Khaled Saad  1 , Ismail L Mohamad  2 , Mohamed A Abd El-Hamed  3 , Mostafa S K Tawfeek  2 , Ahmed E Ahmed  4 , Khaled A Abdel Baseer  4 , Ahmed S El-Shemy  5 , Amira A El-Houfey  6 , Diaa M Tamer  2
Affiliations

A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barré syndrome in Upper Egypt

Khaled Saad et al. Ther Adv Neurol Disord. 2016 Jan.

Abstract

Objective: The aim of our study is to assess the clinico-electrophysiological profile of children with Guillain-Barré syndrome (GBS) in Upper Egypt and to compare the efficacy of plasmapheresis versus other treatment modalities.

Patients and methods: This was a retrospective study of children from January 2010 to October 2014 diagnosed as GBS. It included 62 cases.

Results: Acute inflammatory demyelinating polyradiculoneuropathy (AIDP) was the most prevalent type of GBS in our locality. As regards the treatment, 32 cases received plasmapheresis while 30 patients received intravenous immunoglobulin. We found a significant decrease in the duration of hospitalization and a significant increase in the number of children with complete recovery in cases treated with plasmapheresis.

Conclusion: GBS is not uncommon in children of Upper Egypt, with AIDP the most prevalent type. Plasmapheresis is the best treatment modalities for GBS as it reduces the duration of hospital stay and hastens the recovery of those children.

Keywords: Guillain–Barré Syndrome; children; intravenous immunoglobulin; outcome; plasmapheresis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Agrawal S., Peake D., Whitehouse W. (2007) Management of children with Guillain–Barré syndrome. Arch Dis Child Educ Pract Ed 92: 161–168. - PubMed
    1. Asbury A., Cornblath D. (1990) Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol 27(Suppl.): S21–S24. - PubMed
    1. Chieng K., Hussain N., Gosalakkal J. (2007) Childhood chronic inflammatory demyelinating polyneuropathy secondary to reactivation of Epstein–Barr virus. J Pediatr Neurol 2: 153–156.
    1. Chiò A., Cocito D., Leone M., Giordana M., Mora G., Mutani R. (2003) Guillain–Barré syndrome: a prospective, population based incidence and outcome survey. Neurology 60: 1146–1150. - PubMed
    1. Diener H., Haupt W., Kloss T., Rosenow F., Philipp T., Koeppen S., et al. (2001) A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune absorption in Guillain–Barré syndrome. Eur Neurol 46: 107–109. - PubMed

LinkOut - more resources